Rationale and budget impact of bimonthly use of Cetuximab in patients with recurrent and/or metastatic head and neck cancer von Mennini, FS, Marcellusi, A, Fabiano, G, Platini, F, Bossi, P

Volltext

Late toxicities burden in patients with radioiodine-refractory differentiated thyroid cancer treated with lenvatinib von Platini, F., Cavalieri, S., Alfieri, S., Bergamini, C., Resteghini, C., Bottiglieri, A., Colombo, E., Mazzeo, L., Licitra, L., Paolini, B., Seregni, E., Locati, L. D.

Volltext

Off-label drugs use in home care: a non evidence-based established practice von Velutti, L., Santoro, A., Rimassa, L., Arcanà, C., Platini, F., Pavesi, C., Lopane, D., Speciale, T., Poggio, C., Mazzieri, S.

Volltext

P16.34 BEVACIZUMAB TREATMENT FOR ACOUSTIC NEURINOMA IN NEUROFIBROMATOSIS TYPE 2: A CASE REPORT von Sponghini, A., Rondonotti, D., Platini, F., Giavarra, M., Trevisan, E., Soffietti, R.

Volltext

Pythiosis in Equidae in Northeastern Brazil: 1985–2020 von Souto, Erick Platiní F., Maia, Lisanka A., Neto, Eldine G. Miranda, Kommers, Glaucia D., Junior, Felício Garino, Riet-Correa, Franklin, Galiza, Glauco J.N., Dantas, Antonio F.M.

Volltext

67P High levels of circulating ceramides are associated with poor prognosis in patients with metastatic castration-resistant prostate cancer (mCRPC) von Cattrini, C., Manfredi, M., Barboro, P., Ghirimoldi, M., Mennitto, A., Martini, V., Battioni, A., Le Van, M., Biello, F., Platini, F., Ruffilli, B., Branni, C., Tassone, A., Gobbato, S., Stella, A., Catalano, F., Zanardi, E., Pinato, D.J., Boccardo, F., Gennari, A.

Volltext

38P Evaluation of the prognostic value of innate immunity-related biomarkers in early breast cancer (BC) von Martini, V., D'Avanzo, F., Platini, F., Allesina, M., Favero, F., Corà, D., Rua, A., Saggia, C., Rossi, V., Varughese, F.M., Maggiora, P.M., Ferrante, D., Boldorini, R., Gennari, A.

Volltext

1777P HEME catabolism in peripheral monocytes and response to immune checkpoint inhibitors in advanced lung cancer von Biello, F., Martini, V., Branni, C., Borra, G., Genestroni, S., Mennitto, A., Cattrini, C., Sponghini, A.P., Gatti, A., Platini, F., Rua, A., Maggiora, P.M., Cavalleri, M., Vachanaram, A.R., Varughese, F.M., Ferrante, D., Pinato, D.J., Sica, A., Gennari, A.

Volltext

159P Peripheral T-lymphocytes senescence and response to neoadjuvant therapy (NAT) in operable breast cancer (BC) von D'Avanzo, F., Rossi, V., Saggia, C., Platini, F., Borra, G., Martini, V., Rua, A., Gioffi, E., Branni, C., Maggiora, P.M., Tassone, A., Varughese, F.M., Ram Vachanaram, A., Ben Ayed, R., Angelillo, C., Barcellini, A., Boldorini, R., Dodaro, I., Ferrante, D., Gennari, A.

Volltext

PH-0043: Age related toxicity and outcome in oropharyngeal and nasoparyngeal cancer patients von IvaldI, E., Infante, G., Facchinetti, N., Bossi, P., Iacovelli, N.A., Cavallo, A., Ingargiola, R., Locati, L.D., Bergamini, C., Resteghini, C., Licitra, L., Platini, F., Calareso, G., Fallai, C., Orlandi, E.

Volltext

431PBEVACIZUMAB AND FOTEMUSTINE FOR RECURRENT HIGH GRADE GLIOMAS von Sponghini, A.P., Platini, F., Rondonotti, D., Trevisan, E., Soffietti, R.

Volltext

Bevacizumab and Fotemustine for Recurrent High Grade Gliomas von Sponghini, A.P., Platini, F., Rondonotti, D., Trevisan, E., Soffietti, R.

Volltext

PO-165 Phase 2 study on axitinib in recurrent/metastatic salivary gland cancer of upper aerodigestive tract von Locati, L.D., Cavalieri, S., Bergamini, C., Resteghini, C., Alfieri, S., Calareso, G., Bossi, P., Quattrone, P., Granata, R., Galbiati, D., Platini, F., Orlandi, E., Mariani, L., Licitra, L.

Volltext

Efficacy and safety of the VEGF inhibitor bevacizumab in combination with fotemustine for high-grade gliomas von Sponghini, A.P., Platini, F., Rondonotti, D., Giavarra, M., Patrucco, F., Negru, M.E., Soffietti, R.

Volltext

Breakthrough pain in patients with head and neck cancer: efficacy and safety of buccal fentanyl citrate von Rondonotti, D., Platini, F., Giavarra, M., Patrucco, F., Zanotti, V., Negru, M.E., Sponghini, A.P.

Volltext

38P Assessment of lipidomic profile in endocrine receptor-positive (ER+) MBC patients treated with CDK 4/6 inhibitors (CDKi) and endocrine therapy (ET) von Gennari, A., Manfredi, M., Barberis, E., Branni, C., Ben Ayed, R., Gobbato, S., Alsati, R., Stella, A., Rossi, V., Platini, F., Ruffilli, B., Martini, V.

Volltext

P16.34BEVACIZUMAB TREATMENT FOR ACOUSTIC NEURINOMA IN NEUROFIBROMATOSIS TYPE 2: A CASE REPORT von Sponghini, A., Rondonotti, D., Platini, F., Giavarra, M., Trevisan, E., Soffietti, R.

Volltext

Characterization of the benthic vegetation in the Farwa Lagoon (Libya) von Pergent, G, Djellouli, A, Hamza, A A, Ettayeb, K S, El Mansouri, A A, Talha, F M, Hamza, M A, Pergent-Martini, C, Platini, F

Volltext

P27Kip1 is inactivated in human colorectal cancer by cytoplasmic localization associated with activation of Akt/PKB von BOTTINI, C, PLATINI, F, RINALDI, M, LEUTNER, M, ALABISO, O, GARAVOGLIA, M, TESSITORE, L

Volltext

Characterization of the benthic vegetation in the Farwà Lagoon (Libya) von Pergent, G, Djellouli, A, Hamza, A. A, Ettayeb, K. S, El Mansouri, A. A, Talha, F. M, Hamza, M. A, Pergent-Martini, C, Platini, F

Volltext